Concepedia

Publication | Closed Access

Zoledronic acid induces significant and long-lasting modifications of circulating angiogenic factors in cancer patients.

356

Citations

23

References

2003

Year

Abstract

This study confirms that zoledronic acid could have an in vivo antiangiogenic property through a significant and long-lasting reduction in serum VEGF levels.

References

YearCitations

Page 1